Posted on September 21, 2014

The Supreme Council of Health (SCH) has denied reports circulating through the social media about a recall in Qatar of motilium (domperidone),  a medicine for treating nausea and vomiting, said The Peninsula. The Pharmacy and Drug Control Department at SCH said yesterday that none of the GCC countries including Qatar has imposed a ban nor ordered a recall of the medicine.

The World Health Organisation (WHO), the European Medicine Agency or the British Medical Association (BMA) have also not called for a suspension or recall. International health organisations have only recommended to put rules and regulations on the use of motilium considering its potential side effects, said a statement issued by the department yesterday. It urged doctors to follow the international health guidelines while prescribing the medicine to patients in Qatar.

Qatar Airways Houston

Motilium is associated with the risk of sudden cardiac death and ventricular fibrillation, a life-threatening disruption of the heart’s rhythm. The medicine can be prescribed for treatment of nausea and vomiting only at a dosage of 10mg three times a day by mouth for adults and adolescents or 30mg twice daily as suppositories for one week, the SCH said in a recent circular issued to all healthcare facilities in the country.

The drug should not be prescribed for patients who have suffered heart failure, have cardiac arrhythmias and angina, and a past history of heart attack. The Department urged people to check the facts thoroughly before posting such sensitive items on social media.